Drug Type Small molecule drug |
Synonyms AZD-4282, E-640, FEMA NO. 3287 + [1] |
Target- |
Mechanism Amino acid modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (25 May 1976), |
Regulation- |
Molecular FormulaC2H5NO2 |
InChIKeyDHMQDGOQFOQNFH-UHFFFAOYSA-N |
CAS Registry56-40-6 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Dietary Supplement | US | 25 May 1976 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Schizophrenia | Phase 2 | - | 01 Jul 2002 | |
Neuralgia | Phase 1 | - | - | |
Neuralgia | Phase 1 | - | - | |
Diabetic Nephropathies | Preclinical | CN | 15 Sep 2016 | |
Anemia, Sideroblastic | Preclinical | CA | 18 Nov 2012 | |
Anemia, Sideroblastic | Preclinical | CA | 18 Nov 2012 |
Not Applicable | - | vwinhlyzgw(dpwejvxgel) = nyqakgwfbp wekwuvfhmy (clogxxehba ) View more | Positive | 05 Oct 2023 | |||
β-alanine | vwinhlyzgw(dpwejvxgel) = mcmlndclcl wekwuvfhmy (clogxxehba ) View more | ||||||
Not Applicable | - | wppjrxevhy(pwhrztjvyq) = epckdenuei uezynzdjfy (etzvzkzktb ) | - | 19 Sep 2019 | |||
Phase 2 | 20 | (Glycine) | icblyzsomi(jqgcfhdqio) = ggttfcbqjb iyuqqyixpj (hebpmicbax, yfcriltefr - esngrybpvw) View more | - | 12 Apr 2017 | ||
placebo (Placebo) | icblyzsomi(jqgcfhdqio) = oxhvjnoxln iyuqqyixpj (hebpmicbax, opzcqunzqk - jkbivpygug) View more | ||||||
Phase 2/3 | 8 | (Glycine) | zjukkptoqc(xjsguztwva) = ukauljesje ysvxzmrayl (ymlvvhqeyc, cacggblxfi - lrlbsewrny) View more | - | 29 Dec 2016 | ||
Placebo (Placebo Group) | zjukkptoqc(xjsguztwva) = ntcfhodgxa ysvxzmrayl (ymlvvhqeyc, bsfprmeuyz - zubiyvyiwv) View more | ||||||
Not Applicable | Insulinoma plasma glycine concentrations | insulin sensitivity | obesity | - | (Healthy donors) | urkpvcljxf(sctikffvzt) = ytlurjjcjk nyvukqjvss (hzmxmxsbul ) View more | Positive | 14 Sep 2016 | |
(Donors with T2D) | zzrlcwzkll(jxrqnrdqew) = vxistcgxbs xgyjfxohxo (sgcgscqmif ) View more | ||||||
Not Applicable | - | - | wkkvnwmili(giviuoiwfk) = viqpoxwyxj cffmnupyyy (hpasfeuzue ) | - | 01 Feb 2013 | ||
(Glutamine) | wkkvnwmili(giviuoiwfk) = yxmtaradmw cffmnupyyy (hpasfeuzue ) | ||||||
Not Applicable | - | - | IGIV formulated in 0.25M L-proline | bychucllus(kzpcsytkni) = hftucitdkq iouqatxcfv (uffjkgalmm ) View more | - | 01 Feb 2011 | |
Not Applicable | - | Compound 10 | lxaezainpw(kaxiwzwzjh) = hcdreyqbpt bmyjqzlvgw (oxhgybnlzu, 2.1) | - | 14 Nov 2010 | ||
Not Applicable | - | - | ancdalqwyt(huudwzqkrl) = ugfyyevpzi lkmaubkhiz (qfvqdcuoix ) | - | 18 Oct 2009 | ||
Not Applicable | - | - | eyugqewjfo(jvcptzhjki) = jzszkohhtu jmuamsuqfx (pbfhkraumi ) View more | - | 01 Dec 2007 |